-
Vaccines, Blood & Biologics
-
Resources for You
-
-
Influenza Virus Vaccine, H5N1 (for National Stockpile)
Proper Name: Influenza Virus Vaccine, H5N1
Manufacturer: Sanofi Pasteur Inc, License #1725
Indication:
- For active immunization of persons 18 through 64 years of age at increased risk of exposure to the H5N1 influenza virus subtype contained in the vaccine
-
Supporting Documents
- April 17, 2007 Approval Letter - Influenza Virus Vaccine, H5N1
Indication: For active immunization of persons 18 through 64 years of age at increased risk of exposure to the H5N1 influenza virus subtype contained in the vaccine. - H5N1 Influenza Virus Vaccine Questions and Answers
- FDA Approves First U.S. Vaccine for Humans Against the Avian Influenza Virus H5N1
Press Release: April 17, 2007
-
-
-

